| Entry |
|
|---|
| Name |
Meprobamate (JAN/USP/INN);
Equanil (TN);
Miltown (TN) |
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
C9H18N2O4
|
|---|
| Exact mass |
218.1267
|
|---|
| Mol weight |
218.2502
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG01567 GABA-A receptor agonist
DG02007 Antianxiety, carbamate derivatives
|
|---|
| Remark |
|
|---|
| Efficacy |
Antianxiety, Sedative-hypnotic |
|---|
| Comment |
Carbamate derivative
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05B ANXIOLYTICS
N05BC Carbamates
N05BC01 Meprobamate
D00376 Meprobamate (JAN/USP/INN) <US>
USP drug classification [BR:br08302]
Anxiolytics
Anxiolytics, Other
Meprobamate
D00376 Meprobamate (JAN/USP/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01567 GABA-A receptor agonist
D00376 Meprobamate
DG02007 Antianxiety, carbamate derivatives
D00376 Meprobamate
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
GABA (ionotropic)
GABR
D00376 Meprobamate (JAN/USP/INN) <US>
Narcotics and psychotropics in Japan [br08308.html]
Psychotropics by Cabinet order Article 3 (78 substances)
D00376
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 15
1 C1d C 25.7132 -18.3690
2 C1b C 26.9190 -17.6699
3 C1b C 24.5072 -17.6699
4 C1b C 25.7132 -19.7615
5 C1a C 25.6723 -16.8951
6 O7a O 28.1309 -18.3690
7 O7a O 23.3012 -18.3690
8 C1b C 24.5072 -20.4606
9 C7a C 29.3369 -17.6699
10 C7a C 22.0952 -17.6699
11 C1a C 24.5072 -21.8530
12 N1a N 29.3369 -16.2775
13 O6a O 30.5429 -18.3690
14 N1a N 20.8833 -18.3690
15 O6a O 22.0952 -16.2775
BOND 14
1 1 2 1
2 1 3 1
3 1 4 1
4 1 5 1
5 2 6 1
6 3 7 1
7 4 8 1
8 6 9 1
9 7 10 1
10 8 11 1
11 9 12 1
12 9 13 2
13 10 14 1
14 10 15 2
|
|---|
